Oral anticoagulation is preferable to injected, but only if it is safe and effective: An interview study of patient and carer experience of oral and injected anticoagulant therapy for cancer-associated thrombosis in the select-d trial

BACKGROUND: Cancer patients have a four- to fivefold greater risk of thrombosis than the general population. Recommended treatment for cancer-associated thrombosis is 3–6 months of low-molecular-weight heparin. The ‘select-d’ trial is an open-label, randomised, multi-centre pilot trial in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutchinson, Ann, Rees, Sophie, Young, Annie, Maraveyas, Anthony, Date, Kathryn, Johnson, Miriam J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506899/
https://www.ncbi.nlm.nih.gov/pubmed/30488789
http://dx.doi.org/10.1177/0269216318815377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506899/
https://www.ncbi.nlm.nih.gov/pubmed/30488789
http://dx.doi.org/10.1177/0269216318815377

Ejemplares similares